Insider · CIK 0001789822
Scott B. Brown
Files at TCON (Tracon Pharmaceuticals, Inc.). First filing Jan 3, 2023, latest Jan 3, 2023.
In brief
Scott B. Brown files SEC Form 4 as CFO at TCON (Tracon Pharmaceuticals, Inc.). Since Jan 3, 2023, Scott B. Brown has reported 1 open-market buy worth $5,215 and 0 open-market sells worth $0, the latest filed on Jan 3, 2023.
A track record needs three past buys with six months of prices behind them; Scott B. Brown has 0, so none is measured yet.
The newest scored trade: bought $5,215 of TCON on Dec 29, 2022, filed Jan 3, 2023, scored 25 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | TCONbuy Tracon Pharmaceuticals, Inc. | $5,215 3,500 shares | +19% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Common Stock | +3,500 | $0.14 | $482 | 25,128 | Mar 13, 2024 |
| Mar 12, 2024 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +224,800 | $0.00 | $0 | 224,800 | Mar 13, 2024 |
| Feb 1, 2023 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +144,000 | $0.00 | $0 | 144,000 | Feb 3, 2023 |
| Dec 29, 2022 | TCON Tracon Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +3,500 | $1.49 | $5,215 | 21,628 | Jan 3, 2023 |
Questions about Scott B. Brown
Answered from the filings on this page, as of the latest one.
Is Scott B. Brown buying or selling?
Not in the last 12 months. Scott B. Brown's latest open-market trade on SEC Form 4 was bought $5,215 of TCON on Dec 29, 2022.
How did Scott B. Brown's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott B. Brown has 0.
Where does Scott B. Brown file Form 4?
Scott B. Brown has filed Form 4 at TCON (Tracon Pharmaceuticals, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.